Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Luminex Corporation    LMNX   US55027E1029

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
20.81(c) 18.76(c) 19.03(c) 19.14(c) 19 Last
248 338 1 424 491 538 240 329 189 280 530 Volume
+1.66% -9.85% +1.44% +0.58% -0.73% Change
More quotes
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.It operates its business through two segments: Technology & Strategic Partnerships, and Assays & Related Products.The... 
Surperformance© rating of Luminex Corporation
Trading Rating : Investor Rating :
More about the company
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 227 M
EBIT 2014 29,0 M
Net income 2014 24,2 M
Debt 2014 104 M
Yield 2014 -
Sales 2015 243 M
EBIT 2015 34,3 M
Net income 2015 24,4 M
Debt 2015 132 M
Yield 2015 -
PER 2014 37,71
PER 2015 37,53
EV / Sales 2014 4,07x
EV / Sales 2015 3,92x
Capitalization 820 M
More Financials
Latest news on LUMINEX CORPORATION
3d ago LUMINEX : Reports Third Quarter 2014 Results
3d ago LUMINEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
4d ago LUMINEX : tops 3Q revenue forecasts
4d ago LUMINEX : Results of Operations and Financial Condition, Financial Statements an..
10/22 LUMINEX : Third Quarter Earnings Release Scheduled for October 27, 2014
10/20 LUMINEX : Change in Directors or Principal Officers, Regulation FD Disclosure, F..
10/16 LUMINEX : Announces Retirement of Patrick Balthrop, President and CEO
10/15 LUMINEX : Announces Retirement of Patrick Balthrop, President and CEO
10/13 LUMINEX : Third Quarter Earnings Release Scheduled for October 27, 2014
10/07 LUMINEX : Assigned Patent
10/02 LUMINEX : FDA Clears Luminex to Add Clinical Targets
09/29 LUMINEX : Receives FDA Clearance To Add New Clinical Targets And Additional Samp..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF